These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1606405)

  • 1. High-dose i.v. human immunoglobulin in a case with infantile opsoclonus polymyoclonia syndrome.
    Sugie H; Sugie Y; Akimoto H; Endo K; Shirai M; Ito M
    Acta Paediatr; 1992 Apr; 81(4):371-2. PubMed ID: 1606405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Opsoclonus-myoclonus in a patient with AIDS: a good response to treatment with IV immunoglobulins].
    García-Morales I; Porta-Etessam J; Saiz-Díaz R; Gómez-Escalonilla C; Galán L; Parrilla G; Molina JA
    Rev Neurol; 1999 Dec 16-31; 29(12):1346-8. PubMed ID: 10652770
    [No Abstract]   [Full Text] [Related]  

  • 3. Opsoclonus polymyoclonia syndrome.
    Penzien JM; Speck S; Vassella F
    Acta Paediatr; 1993 Mar; 82(3):319-20. PubMed ID: 8495095
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of opsoclonus-myoclonus-ataxia with neuroblastoma.
    Mukherjee A; Mukherjee A; Chakrabarty S
    J Indian Med Assoc; 2004 Nov; 102(11):647-8. PubMed ID: 15868878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opsoclonus--myoclonus syndrome in an adult: a case report and response to clonazepam.
    Garg RK; Kar AM; Dixit V
    Indian J Ophthalmol; 1996 Jun; 44(2):101-2. PubMed ID: 8916599
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of poststreptococcal opsoclonus-myoclonus syndrome.
    Dassan P; Clarke C; Sharp DJ
    Mov Disord; 2007 Jul; 22(10):1490-1491. PubMed ID: 17486621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of opsoclonus-myoclonus with high-dose intravenous immunoglobulin.
    Pless M; Ronthal M
    Neurology; 1996 Feb; 46(2):583-4. PubMed ID: 8614543
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcome of children with opsoclonus-myoclonus regardless of etiology.
    Hammer MS; Larsen MB; Stack CV
    Pediatr Neurol; 1995 Jul; 13(1):21-4. PubMed ID: 7575843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurobehavioral and psychosocial functioning of children with opsoclonus-myoclonus syndrome.
    Papero PH; Pranzatelli MR; Margolis LJ; Tate E; Wilson LA; Glass P
    Dev Med Child Neurol; 1995 Oct; 37(10):915-32. PubMed ID: 7493725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma.
    Koh PS; Raffensperger JG; Berry S; Larsen MB; Johnstone HS; Chou P; Luck SR; Hammer M; Cohn SL
    J Pediatr; 1994 Nov; 125(5 Pt 1):712-6. PubMed ID: 7525913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Opsoclonus-polymyoclonia syndrome].
    Shimizu N
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):203-5. PubMed ID: 10434631
    [No Abstract]   [Full Text] [Related]  

  • 12. Chlormethiazole in the management of the opsoclonus-myoclonus syndrome.
    Vilchez JJ; Lago A; Burguera JA; Yaya R; Casanova V
    J Int Med Res; 1994; 22(1):55-62. PubMed ID: 8187945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of steroid and high-dose immunoglobulin therapy on opsoclonus-myoclonus syndrome occurring in neuroblastoma.
    Veneselli E; Conte M; Biancheri R; Acquaviva A; De Bernardi B
    Med Pediatr Oncol; 1998 Jan; 30(1):15-7. PubMed ID: 9371383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab and intravenous immunoglobulins for relapsing postinfectious opsoclonus-myoclonus syndrome.
    Leen WG; Weemaes CM; Verbeek MM; Willemsen MA; Rotteveel JJ
    Pediatr Neurol; 2008 Sep; 39(3):213-7. PubMed ID: 18725071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune globulin G for treatment of opsoclonus-polymyoclonus syndrome.
    Eirís J; del Rió M; Castro-Gago M
    J Pediatr; 1996 Jul; 129(1):175. PubMed ID: 8757584
    [No Abstract]   [Full Text] [Related]  

  • 16. Controlled pilot study of piracetam for pediatric opsoclonus-myoclonus.
    Pranzatelli MR; Tate ED; Galvan I; Wheeler A
    Clin Neuropharmacol; 2001; 24(6):352-7. PubMed ID: 11801811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rare clinical presentation of COVID 19: opsoclonus-myoclonus ataxia syndrome.
    Altunsoy A; Kemirtlek N; Araz H; Dirik EB; Akıncı E
    J Infect Dev Ctries; 2024 Feb; 18(2):188-194. PubMed ID: 38484346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infantile polymyoclonia-opsoclonus syndrome and neural crest tumors.
    Moe PG; Nellhaus G
    Neurology; 1970 Aug; 20(8):756-64. PubMed ID: 4318291
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sibling cases of opsoclonus-polymyoclonus syndrome].
    Fujimoto Y; Isozaki E; Tanaka K; Kikuchi M; Hirai S
    Rinsho Shinkeigaku; 1997 Mar; 37(3):261-3. PubMed ID: 9217429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opsoclonus.
    Amin OS; Shwani SS
    BMJ Case Rep; 2017 Feb; 2017():. PubMed ID: 28202488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.